Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    27-October-2000      
Issue 197 Next Update - 14:00 UTC 08:00 EST    28-October-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 27-October-2000:

Available data suggest that violence against women (VAW) (i.e., both adolescents and adults) is a substantial public health problem in the United States. Law enforcement data indicate that 3,419 females died in 1998 as a result of homicide, and approximately one third of these women were murdered by a spouse, ex-spouse, or boyfriend. Get a report that provides recommendations regarding public health surveillance and research on violence against women in today's Vidyya.

Medeva Pharmaceuticals has reported that results from a Phase III clinical trial of a modified release formulation of methylphenidate hydrochloride for the treatment of attention deficit hyperactivity disorder (ADHD) were presented in abstract form at the 47th annual American Academy of Child and Adolescent Psychiatry (AACAP) meeting in New York City. The primary objective of the study was to compare the efficacy, safety and tolerability of once daily (before school) administration of methylphenidate modified release capsules.

Nearly 6,000 pediatricians and medical professionals will gather at the American Academy of Pediatrics (AAP) Annual Meeting at the Lakeside Center at McCormick Place from Friday, 27 October through Wednesday, 01 November. The AAP is the national association of 55,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists and is widely perceived as the nation's foremost authority on children's health. This Vidyya has the meeting agenda for you.

In international research news, China has developed Stavudine for the treatment of AIDS. The drug was developed by a group of researchers at the Xi'an Jiatong University lead by Lu Yong, an associate professor. The drug has been approved by the Nanjing University Analysis Center and is under batch production for export. China is the third country to manufacture the drug and will do so at very low cost.

And closer to home, soy has "consistently lowered both total cholesterol and LDL (bad) cholesterol " in randomized tests, a health publication of Harvard Medical School reports.

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.